… nucleic acid vaccines. By mid-2021 three billion doses of COVID-19 vaccine have been
administered around the world, mostly in high-income countries. COVID-19 vaccination provides …

… the most promising vaccine candidates. COVID-19 vaccine R&D landscape As of 8 April
2020, the global COVID-19 vaccine R&D landscape includes 115 vaccine candidates (Fig. 1), of …

… efficacy testing and what to expect from the global vaccine effort over the next few years. …
design of COVID-19 vaccine strategies and analyses the current COVID-19 vaccine landscape …

… COVID-19 vaccine; 2) unemployed participants reported lower influenza uptake and lower
COVID-19 vaccine … lower influenza vaccine uptake and lower COVID-19 vaccine acceptance …

… We aggregated confidence in the COVID-19 vaccine into very confident and confident …
between the outcome and confidence in the COVID-19 vaccine. We did the same for the variable …

… of the COVID-19 pandemic is driving evaluation of nextgeneration vaccine technology
platforms through novel paradigms to accelerate development, and the first COVID-19 vaccine …

… , and vaccine registry databases. We assessed vaccine effectiveness against Covid-19
from May 1 through September 3, 2021, and against hospitalization with Covid-19 from May …

… around the world to develop a vaccine against this virus. Three vaccines with more than 90%
… threat worldwide and development of new COVID-19 vaccines remains essential. In The …

… A 69-year old receives a COVID-19 vaccine in a Phase 3 trial. It is important to understand
how different groups respond to COVID-19 vaccines to establish the most effective …

… the outbreak of novel coronavirus erupted and then world-… COVID-19 vaccine before
September, 2020 as per very optimistic estimates. This is because a successful COVID-19 vaccine …